Condition

Metastatic Triple-negative Breast Cancer clinical trials and research

• 6Clinical trials
• 3Countries

Newest Metastatic Triple-negative Breast Cancer clinical trials

All recruiting trials (6)

• BEBT-209 plus chemotherapy in advanced/metastatic triple-negative breast cancer

  A new drug, BEBT-209, is being tested with standard chemotherapy to see if it helps people with locally advanced or metastatic triple-negative breast cancer.

  Recruiting at 2 sites Phase 2/3 BeBetter Med Inc · Guangzhou, Guangdong and 1 other locations · NCT07544056

• TASTY taste-steering for chemotherapy-related taste changes

  This trial tests whether an at-home 'taste steering' program helps adults on chemotherapy for metastatic triple-negative breast cancer, metastatic testicular cancer, or stage II–IV diffuse large B cell lymphoma enjoy food more.

  Recruiting at 6 sites University Medical Center Groningen · Amsterdam and 10 other locations · NCT07258563

• Naxitamab plus sacituzumab govitecan for metastatic triple-negative breast cancer

  This trial will test whether combining naxitamab with sacituzumab govitecan helps adults with metastatic triple-negative breast cancer.

  Recruiting Phase 1/2 M.D. Anderson Cancer Center · Houston, Texas · NCT07011654

• Sacituzumab govitecan with nivolumab, with or without relatlimab, for metastatic triple-negative breast cancer

  This trial tests whether adding nivolumab alone or nivolumab plus relatlimab to sacituzumab govitecan helps people with metastatic triple-negative breast cancer who have had one prior line of chemotherapy.

  Recruiting Phase 1/2 Yale University · New Haven, Connecticut · NCT06963905

• Evaluating Trop2-ADC treatment for advanced triple-negative breast cancer

  This study is testing a new treatment called Trop2-ADC, alone or with other therapies, to see if it helps people with advanced triple-negative breast cancer.

  Recruiting Phase 2 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT06851299

• Combining SDX-7320 with Eribulin for Treating Breast Cancer

  This study is testing if adding the drug SDX-7320 to the standard chemotherapy eribulin can help people with metastatic triple-negative breast cancer and metabolic issues feel better.

  Recruiting at 10 sites Phase 2 Memorial Sloan Kettering Cancer Center · Miami, Florida and 9 other locations · NCT05570253

Related topics

Quick answers

How many Metastatic Triple-negative Breast Cancer clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (3 trials), China (2 trials), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1/2: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →